StockData
Oncolytics Biotech Inc logo

Oncolytics Biotech Inc (ONCY) stock

ONCYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 10-Q on Nov 13, 2026Score 0/30
$0.44+0.06 (+15.11%)

Close on Nov 18, 2026Market cap $56.14MP/E –Yield –

Earnings

Oncolytics Biotech's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue, Q4 FY2021
–
EPS, Q4 FY2021
-0.14 CAD
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Oncolytics Biotech's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2021ended Dec 31, 2021Mar 3, 2022after the close––-0.14 CADRelease

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Oncolytics Biotech has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Oncolytics Biotech puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Oncolytics Biotech filed with the SEC as exhibits to Form 8-K or 6-K

  1. News
  2. News
  3. News
  4. News
  5. News
  6. News
  7. News
  8. News
  9. News
  10. News
  11. News
  12. News
  13. News
  14. News
  15. News

See a number that looks wrong?